PPT-Precision Medicine: Levels of Evidence Required for Reporting Variants and Guiding Patient

Apostolia M Tsimberidou MD PhD Professor Investigational Cancer Therapeutics Incorporation of Levels of Evidence into Variant ReportingClinical Practice Implementation of CAP AMP ASCO recommendations. (...healthcare) . You are working in a community team and a few of the CNSs consistently advise dexamethasone 8 mg od for non specific cancer related breathlessness.. How would explain EBM to the team?. From Promise to Practice. PRECISION ONCOLOGY IS THE FUTURE OF CANCER CARE.. Tumor genome data informs cancer treatment and clinical pathways, resulting in better health outcomes.. New cancer therapies target the molecular pathways that lead to tumor genesis and progression.. National Human Genome Research Institute. National Institutes of Health. U.S. Department of Health and Human Services. U.S. Department of Health and Human Services. National Institutes of Health. National Human Genome Research Institute. Dr Howard L. McLeod. Medical Director, DeBartolo Family. Personalized Medicine Institute. Chair, Department of Individualized Cancer Medicine. Senior Member, Division of Population Sciences. State of Florida Endowed Chair. Monday, November 14, 2016. Session Objectives. Understand . Precision Medicine and why a diverse cohort is crucial for success. Describe the nuanced issues in Precision Medicine and genetic research as applied to Native populations. 1. 2015 Precision Medicine Initiative: . Two Components: Cancer & National Cohort. “. An emerging approach for disease prevention and treatment that takes into account people’s individual variations in genes, environment, and lifestyle”. Jeremy Warner . MD, MS. Assistant Professor of Medicine and Biomedical . Informatics. Vanderbilt University. June 26, 2017. Three questions every cancer patient asks. Who’s like me?. How long have I got?. NASF 10 x 25 Summit. Technology Update. Spine Education and Research Center(SERC). Burr Ridge, IL.. July 15, 2016. THE FIRST LAW OF EBM. Given enough statistics you can prove anything.. THE SECOND LAW OF EBM. NASF 10 x 25 Summit. Technology Update. Spine Education and Research Center(SERC). Burr Ridge, IL.. July 15, 2016. THE FIRST LAW OF EBM. Given enough statistics you can prove anything.. THE SECOND LAW OF EBM. ) is . about systematically . reviewing, appraising, and using clinical research findings to aid the delivery of optimum clinical care to patients. . Patient . knowledge of . EBM . is important because it enables them to make more informed decisions about disease management and treatment. . \4\2019. 4. th stage . By Dr Muslim . N.Saeed. . 1. Learning Objectives. To discuss the relevance of Evidence-Based Medicine. To define Evidence-Based Medicine. To list the different levels of evidence . primary care . setting. . Evidence based medicine has had an increasing impact on primary care over the last few years. . In . the . UK it . has influenced the development of . :. Guidelines. Quality . Karen L. Edwards, . PhD. Professor, Dept. of Epidemiology. School of Medicine. University of . California, Irvine. Irvine, CA. Outline. Two National Initiatives . Precision Medicine Initiative . Cancer . Owen Tan. 1. , Deborah Schofield. 1. , Rupendra Shrestha. 1. 1. GenIMPACT: Centre for Economic Impacts of Genomic Medicine, Macquarie Business School, Macquarie University, Australia.. Presenting at: .